摘要
重组人血小板生成素是高特异性的血小板刺激因子，直接作用于骨髓造血干细胞，调控血小板生成的各个阶段，特异性升。高血小板。适用于实体瘤化疗后所致的血小板减少症，适用对象为血小板低于50×10^9·L^-1且有必要升高血小板的患者。现对其药理作用、药动学等作具体论述。
Recombinant human thrombopoietin is a specific platelet stimulating factor which affect directly bone marrow haemopoietic stem cell,and regulate every stage of thrombocytopoiteic , to heighten platelet specially. It is suitable： for treatment of chemotheraphy- induced thrombocytopenia in solid tumor patients. Patient with low platelet as applicable object. To disscuss pharmacologic action and pharmacokinetics of recombinant human thrombopoietin .
出处
《新医学导刊》
2008年第5期12-13,共2页
New Medical Science
